These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17460232)

  • 1. Cardiovascular risks of antiretroviral therapy.
    Stein JH
    N Engl J Med; 2007 Apr; 356(17):1773-5. PubMed ID: 17460232
    [No Abstract]   [Full Text] [Related]  

  • 2. Class of antiretroviral drugs and the risk of myocardial infarction.
    ; Friis-Møller N; Reiss P; Sabin CA; Weber R; Monforte Ad; El-Sadr W; Thiébaut R; De Wit S; Kirk O; Fontas E; Law MG; Phillips A; Lundgren JD
    N Engl J Med; 2007 Apr; 356(17):1723-35. PubMed ID: 17460226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral drugs and the risk of myocardial infarction.
    Pollack TM; Rind DM
    N Engl J Med; 2007 Aug; 357(7):716; author reply 716-7. PubMed ID: 17703531
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral drugs and the risk of myocardial infarction.
    Kaplan RC; Tien PC; Lazar J
    N Engl J Med; 2007 Aug; 357(7):715; author reply 716-7. PubMed ID: 17699825
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiretroviral drugs and the risk of myocardial infarction.
    Zangerle R; Sarcletti M
    N Engl J Med; 2007 Aug; 357(7):715-6; author reply 716-7. PubMed ID: 17703532
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome: news from the 4th International AIDS Society Conference.
    Valenti WM
    AIDS Read; 2007 Sep; 17(9):435-7. PubMed ID: 17902223
    [No Abstract]   [Full Text] [Related]  

  • 8. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antiretroviral therapy and the risk of myocardial infarction.
    Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD;
    N Engl J Med; 2003 Nov; 349(21):1993-2003. PubMed ID: 14627784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk?
    Gilleece Y; Nelson M
    J HIV Ther; 2001 May; 6(2):37-9. PubMed ID: 11501202
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoprotein(a) in patients initiating antiretroviral therapy.
    Mauss S; Berger F; Schmutz G; Henke J; Richter WO
    HIV Med; 2008 Jul; 9(6):415-20. PubMed ID: 18459949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic side effects of antiretroviral therapy].
    van der Valk M; Reiss P
    Ned Tijdschr Geneeskd; 2008 May; 152(22):1260-4. PubMed ID: 18590059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
    Introcaso CE; Hines JM; Kovarik CL
    J Am Acad Dermatol; 2010 Oct; 63(4):549-61; quiz 561-2. PubMed ID: 20846563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral therapies.
    Owen WF
    Clin Podiatr Med Surg; 1998 Apr; 15(2):227-39. PubMed ID: 9576051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy increases risk of heart attack.
    Gottlieb S
    BMJ; 2003 Nov; 327(7425):1186. PubMed ID: 14630739
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New HIV guidelines offer adverse effects data.
    AIDS Alert; 2002 Jul; 17(7):89-91. PubMed ID: 12116974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
    Bozzette SA; Ake CF; Tam HK; Chang SW; Louis TA
    N Engl J Med; 2003 Feb; 348(8):702-10. PubMed ID: 12594314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.